Hackett Group (NASDAQ:HCKT) Stock, Quote.Headers.trade-ideas

The Hackett Group

The Hackett Group Inc is an IP-based executive advisory, strategic consulting, and digital transformation firm. It provides Generative Artificial Intelligence ("Gen AI") strategy, operations, finance, human capital management, strategic sourcing, procurement, and information technology. It operates in three segments Oracle Solutions, SAP Solutions, and Global S&BT. It generates the majority of its revenue from the Global S&BT segment in the United States.

Hackett Group

News

Penny Stocks

Small Cap

Intraday Update

Markets

Movers

Trading Ideas

AMPL

ATCH

AVGR

BFRI

BLCO

CPOP

EFOI

GBNH

GRMN

HCKT

IOVA

JANX

LIVN

MOTS

MTTR

PANW

PLAB

RAPT

SEDG

SEED

SISI

SNCR

SOGP

TDOC

THRM

TRTX

UCAR

VTYX

WTTR

Shares of  International Flavors &amp; Fragrances Inc. (NYSE: IFF) fell during Wednesday’s session after the company reported mixed fourth-quarter financial results and reduced its expected quarterly dividend approximately 50% to 40 cents per share.

Why International Flavors &amp; Fragrances Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday&#39;s Mid-Day Session

CSTM

U.S. stocks were lower, with the Nasdaq Composite falling more than 100 points on Wednesday.

Toll Brothers Posts Upbeat Earnings, Joins Exelon, Garmin, Bausch + Lomb And Other Big Stocks Moving Higher On Wednesday

Short Ideas

Pre-Market Outlook

NNDM

PWSC

The most overbought stocks in the information technology sector presents an opportunity to go short on these overvalued companies.

Top 5 Tech Stocks That May Crash This Month

The Hackett Group Inc

Barrington Research analyst Vincent Colicchio maintains Hackett Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCKT#NASDAQ">HCKT</a>) with a Outperform and maintains $28 price target.

Price Target

Analyst Ratings

Barrington Research Maintains Outperform on Hackett Group, Maintains $28 Price Target

The Hackett Group Acquires Gen AI Development Firm LeewayHertz, Combining AI XPLR And ZBrain.ai Platforms To Offer Comprehensive Gen AI Solutions From Ideation To Implementation; Acquisition Aims To Accelerate Clients' AI Transformation And Enhance ROI

Barrington Research analyst Vincent Colicchio maintains Hackett Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCKT#NASDAQ">HCKT</a>) with a Outperform and raises the price target from $26 to $28.

Barrington Research Maintains Outperform on Hackett Group, Raises Price Target to $28

Guidance

Hackett Group Estimates Q3 Total Revenue Before Reimbursements Of $74.5M - $76.0M, Adj EPS Of $0.39 - $0.41, Est $0.40

The Hackett Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCKT#NASDAQ">HCKT</a>) reported quarterly earnings of $0.39 per share which beat the analyst consensus estimate of $0.37 by 5.41 percent. The company reported quarterly sales of $77.656 million which beat the analyst consensus estimate of $75.705 million by 2.58 percent. This is a 0.72 percent increase over sales of $77.102 million the same period last year.

Earnings

Earnings Beats

The Hackett Group Q2 2024 Adj. EPS $0.39 Beats $0.37 Estimate, Sales $77.656M Beat $75.705M Estimate

Provides Comprehensive Payroll Support Including Business Process Outsourcing, Staff Support, And Best Practices For Payroll Optimization

ORCL

The Hackett Group Collaborates With Oracle To Offer Hackett Pay Managed Services For Oracle Payroll

The Hackett Group Integrates Generative AI Insights Into Executive Advisory Programs; AI XPLR Platform Empowers Executives With Comprehensive Plans For Gen AI Deployment

Barrington Research analyst Vincent Colicchio maintains The Hackett Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCKT#NASDAQ">HCKT</a>) with a Outperform and maintains $26 price target.

Barrington Research Maintains Outperform on The Hackett Group, Maintains $26 Price Target

Barrington Research analyst Vincent Colicchio maintains The Hackett Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCKT#NASDAQ">HCKT</a>) with a Outperform and lowers the price target from $28 to $26.

Barrington Research Maintains Outperform on The Hackett Group, Lowers Price Target to $26

Business Outlook for the Second Quarter of 2024
Based on the Company's current outlook:
<ul>
<li>The Company estimates total revenue before reimbursements for the second quarter of 2024 will be in the range of $73.5 million to $75.0 million.</li>
<li>The Company estimates adjusted diluted earnings per share for the second quarter of 2024 to be in the range of $0.36 and $0.39, which assumes a GAAP effective tax rate of 27.2%.</li>
</ul>

The Hackett Group Sees Q2 EPS $0.36-$0.39 Vs $0.42 Est.; Revenue $73.5M-$75M Vs $78.3M Est.

The Hackett Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCKT#NASDAQ">HCKT</a>) reported quarterly earnings of $0.39 per share which beat the analyst consensus estimate of $0.37 by 5.41 percent. This is a 5.41 percent increase over earnings of $0.37 per share from the same period last year. The company reported quarterly sales of $77.19 million which beat the analyst consensus estimate of $74.55 million by 3.54 percent. This is a 8.36 percent increase over sales of $71.23 million the same period last year.

The Hackett Group Q1 EPS $0.39 Beats $0.37 Estimate, Sales $77.19M Beat $74.55M Estimate

Shares of International Flavors &amp; Fragrances Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/iff#NYSE">IFF</a>) fell during Wednesday&rsquo;s session after the company reported mixed fourth-quarter financial results and reduced its expected quarterly dividend approximately 50% to 40 cents per share.
International Flavors &amp; Fragrances shares dipped 8.4% to $75.11 on Wednesday.
Here are some other stocks moving in today&#39;s mid-day session.
<h3>Gainers</h3>
<ul>
<li>Greenbrook TMS Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gbnh#NASDAQ">GBNH</a>) climbed 120.8% to $0.4351. Greenbrook TMS raised $2.5 million in debt financing.</li>
<li>Emergent BioSolutions Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ebs#NYSE">EBS</a>) gained 84% to $2.8050. Emergent BioSolutions appointed Joseph Papa as President and CEO, effective Feb. 21, 2024.</li>
<li>Ventyx Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vtyx#NASDAQ">VTYX</a>) gained 77.2% to $5.30. Traders circulated unconfirmed analyst comments suggesting co might be the next big weight loss drug citing a new publication showing NLRP3 has significant weight loss similar to GLP-1.</li>
<li>Sound Group Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sogp#NASDAQ">SOGP</a>) shares rose 63.1% to $4.60. Sound Group announced the launch of new AI-powered applications.</li>
<li>Motus GI Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mots#NASDAQ">MOTS</a>) shares rose 59.4% to $1.04 after the company was granted U.S. Patent #11904085 for &#39;Systems And Methods For Cleaning A Colon.&#39;</li>
<li>Origin Agritech Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/seed#NASDAQ">SEED</a>) gained 34% to $3.11. Origin Agritech increased revenue by 77% year-over-year for the fiscal year ended Sep. 30, 2023.</li>
<li>Gentherm Incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/thrm#NASDAQ">THRM</a>) shares jumped 24.7% to $61.48 after the company reported better-than-expected fourth-quarter financial results and issued guidance.</li>
<li>RAPT Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rapt#NASDAQ">RAPT</a>) gained 24% to $8.52.</li>
<li>Energy Focus, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/efoi#NASDAQ">EFOI</a>) shares jumped 23.4% to $1.7050.</li>
<li>MediaAlpha, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/max#NYSE">MAX</a>) rose 19% to $18.80 after the company reported better-than-expected fourth-quarter financial results.</li>
<li>Janux Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/janx#NASDAQ">JANX</a>) gained 18% to $11.75. Janux Therapeutics will host virtual event on Feb. 26th, 2024, at 4:30PM ET to discuss updated clinical data for PSMA-TRACTr JANX007 and EGFR-TRACTr JANX008.</li>
<li>Iovance Biotherapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/iova#NASDAQ">IOVA</a>) rose 15.9% to $13.95.</li>
<li>TPG RE Finance Trust, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/trtx#NYSE">TRTX</a>) jumped 12.9% to $6.24 after the company reported fourth-quarter financial results.</li>
<li>Garmin Ltd.(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/grmn#NYSE">GRMN</a>) rose 12.2% to $137.72 after the company reported fourth-quarter financial results and issued FY24 revenue guidance above estimates, recommended boosting annual dividend and authorized share buyback.</li>
<li>Select Water Solutions, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/wttr#NYSE">WTTR</a>) gained 11.7% to $8.77 following strong earnings.</li>
<li>The Hackett Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hckt#NASDAQ">HCKT</a>) surged 11.2% to $25.48 following upbeat results.</li>
<li>LivaNova PLC (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/livn#NASDAQ">LIVN</a>) jumped 8.8% to $57.28 following upbeat earnings.</li>
<li>EQT Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/eqt#NYSE">EQT</a>) gained 8.8% to $36.69.</li>
<li>Wix.com Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wix#NASDAQ">WIX</a>) gained 8.6% to $136.15 following fourth-quarter results.</li>
<li>Bausch + Lomb Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/blco#NYSE">BLCO</a>) gained 8.6% to $15.84 after reporting quarterly results.</li>
<li>Wix.com Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wix#NASDAQ">WIX</a>) gained 8.2% to $135.56 following fourth-quarter results.</li>
<li>NeoGenomics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/neo#NASDAQ">NEO</a>) rose 7.4% to $15.78 after the company reported better-than-expected fourth-quarter financial results and issued FY24 adjusted EPS guidance above estimates.</li>
<li>Toll Brothers, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tol#NYSE">TOL</a>) gained 6.6% to $110.42 after the company reported better-than-expected first-quarter financial results and issued FY24 EPS guidance above estimates.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>AtlasClear Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/atch#NYSE">ATCH</a>) shares tumbled 41% to $1.19.</li>
<li>Shineco, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sisi#NASDAQ">SISI</a>) dipped 33.4% to $1.53 after gaining around 56% on Tuesday.</li>
<li>Synchronoss Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sncr#NASDAQ">SNCR</a>) fell 32.2% to $8.30.</li>
<li>U Power Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ucar#NASDAQ">UCAR</a>) dipped 30% to $0.0710 after the company received a delisting notice from the Nasdaq Stock Market due to its ordinary shares&rsquo; closing bid price falling below $0.10 for ten consecutive trading days, as per the Low Priced Stocks Rule.</li>
<li>MoneyHero Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mny#NASDAQ">MNY</a>) fell 28% to $2.2259.</li>
<li>Community Health Systems, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cyh#NYSE">CYH</a>) fell 27.3% to $2.9350 after the company reported fourth-quarter financial results.</li>
<li>Palo Alto Networks, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/panw#NASDAQ">PANW</a>) shares dipped 26.2% to $270.29 after the company issued third-quarter guidance below estimates.</li>
<li>Teladoc Health, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tdoc#NYSE">TDOC</a>) shares fell 25.3% to $15.31 after the company reported mixed fourth-quarter financial results and issued weak guidance.</li>
<li>Unisys Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/uis#NYSE">UIS</a>) fell 24.5% to $5.88 after the company reported quarterly financial results.</li>
<li>Pop Culture Group Co., Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cpop#NASDAQ">CPOP</a>) fell 21.3% to $5.66 after jumping 171% on Tuesday.</li>
<li>Amplitude, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ampl#NASDAQ">AMPL</a>) fell 16.6% to $11.73 after the company reported mixed fourth-quarter financial results and issued weak guidance.</li>
<li>SolarEdge Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sedg#NASDAQ">SEDG</a>) shares fell 15.7% to $71.20 after the company reported mixed fourth-quarter financial results.</li>
<li>Matterport, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mttr#NASDAQ">MTTR</a>) shares fell 15.4% to $2.1450 after the company posted weak quarterly sales and issued downbeat forecast.</li>
<li>Zscaler, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zs#NASDAQ">ZS</a>) fell 14.8% to $212.15.</li>
<li>Medifast, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/med#NYSE">MED</a>) declined 14.3% to $41.95 after the company issued weak guidance.</li>
<li>Avinger, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/avgr#NASDAQ">AVGR</a>) shares fell 14.3% to $4.57 after surging 83% on Tuesday.</li>
<li>Photronics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/plab#NASDAQ">PLAB</a>) fell 13% to $27.17 after the company reported first-quarter financial results below estimates.</li>
<li>Workiva Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/wk#NYSE">WK</a>) fell 12.3% to $82.55 following quarterly results.</li>
<li>Fisker Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/fsr#NYSE">FSR</a>) fell 11.4% to $0.5582.</li>
<li>Biofrontera Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bfri#NASDAQ">BFRI</a>) shares fell 6.1% to $1.0794. Biofrontera shares jumped 53% on Tuesday after the company announced a private placement of up to $16 million priced at the market per Nasdaq rules.</li>
<li>Sprout Social, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/spt#NASDAQ">SPT</a>) shares declined 5.4% to $61.01 after the company reported fourth-quarter financial results and issued guidance.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/markets/cryptocurrency/24/02/37237721/bitcoin-falls-below-51-000-starknet-becomes-top-loser"> Bitcoin Falls Below $51,000; Starknet Becomes Top Loser</a>

Why International Flavors & Fragrances Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

<h3>Gainers</h3>
<ul>
<li>Locafy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LCFY#NASDAQ">LCFY</a>) stock increased by 13.5% to $6.81 during Wednesday's regular session. The company's market cap stands at $8.6 million. </li>
<li>Movano (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MOVE#NASDAQ">MOVE</a>) shares moved upwards by 12.29% to $0.63. The company's market cap stands at $35.0 million. </li>
<li>The Hackett Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCKT#NASDAQ">HCKT</a>) stock increased by 9.33% to $25.06. The company's market cap stands at $682.5 million. As per the news, the Q4 earnings report came out yesterday. </li>
<li>CSP (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSPI#NASDAQ">CSPI</a>) stock moved upwards by 8.89% to $32.45. The company's market cap stands at $157.6 million. </li>
<li>MMTEC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTC#NASDAQ">MTC</a>) stock increased by 8.46% to $1.41. The company's market cap stands at $280.7 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Synchronoss Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNCR#NASDAQ">SNCR</a>) stock fell 30.6% to $8.5 during Wednesday's regular session. The market value of their outstanding shares is at $88.1 million. </li>
<li>Palo Alto Networks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PANW#NASDAQ">PANW</a>) stock decreased by 27.15% to $266.71. The market value of their outstanding shares is at $84.0 billion. The company's, Q2 earnings came out yesterday. </li>
<li>Unisys (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UIS#NYSE">UIS</a>) shares declined by 26.54% to $5.73. The company's market cap stands at $391.8 million. As per the news, the Q4 earnings report came out today. </li>
<li>Matterport (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTTR#NASDAQ">MTTR</a>) shares decreased by 17.92% to $2.08. The market value of their outstanding shares is at $637.3 million. As per the news, the Q4 earnings report came out yesterday. </li>
<li>Intrusion (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTZ#NASDAQ">INTZ</a>) shares decreased by 16.81% to $0.21. The company's market cap stands at $7.5 million. </li>
<li>CISO Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CISO#NASDAQ">CISO</a>) stock decreased by 15.86% to $0.12. The company's market cap stands at $22.2 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CISO

CSPI

INTZ

LCFY

MOVE

11 Information Technology Stocks Moving In Wednesday's Intraday Session

Barrington Research analyst Vincent Colicchio reiterates The Hackett Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCKT#NASDAQ">HCKT</a>) with a Outperform and maintains $28 price target.

Reiteration

Barrington Research Reiterates Outperform on The Hackett Group, Maintains $28 Price Target

WIIM

The Hackett Group shares are trading higher after the company reported better-than-expected Q4 financial results. Following earnings, Craig-Hallum upgraded the stock from Hold to Buy.

U.S. stocks were lower, with the Nasdaq Composite falling more than 100 points on Wednesday.
Shares of Toll Brothers, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tol#NYSE">TOL</a>) gained during Wednesday&rsquo;s session after the company reported better-than-expected first-quarter financial results and <a href="https://www.benzinga.com/news/earnings/24/02/37234324/why-is-toll-brothers-stock-trading-higher-wednesday">issued FY24 EPS guidance above estimates</a>.
The company reported first-quarter 2024 earnings per share of $2.25, beating the analyst consensus of $1.78. Quarterly revenues of $1.948 billion beat the street view of $1.859 billion.
Toll Brothers shares rose 6.2% to $109.93 on Wednesday.
Here are some other big stocks recording gains in today&rsquo;s session.
<ul>
<li>Gentherm Incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/thrm#NASDAQ">THRM</a>) shares jumped 24.7% to $61.48 after the company reported better-than-expected fourth-quarter financial results and issued guidance.</li>
<li>MediaAlpha, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/max#NYSE">MAX</a>) rose 19% to $18.80 after the company reported better-than-expected fourth-quarter financial results.</li>
<li>Janux Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/janx#NASDAQ">JANX</a>) gained 18% to $11.75. Janux Therapeutics will host virtual event on Feb. 26th, 2024, at 4:30PM ET to discuss updated clinical data for PSMA-TRACTr JANX007 and EGFR-TRACTr JANX008.</li>
<li>Iovance Biotherapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/iova#NASDAQ">IOVA</a>) rose 15.9% to $13.95.</li>
<li>TPG RE Finance Trust, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/trtx#NYSE">TRTX</a>) jumped 12.9% to $6.24 after the company reported fourth-quarter financial results.</li>
<li>Garmin Ltd.(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/grmn#NYSE">GRMN</a>) rose 12.2% to $137.72 after the company reported fourth-quarter financial results and issued FY24 revenue guidance above estimates, recommended boosting annual dividend and authorized share buyback.</li>
<li>Select Water Solutions, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/wttr#NYSE">WTTR</a>) gained 11.7% to $8.77 following strong earnings.</li>
<li>The Hackett Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hckt#NASDAQ">HCKT</a>) surged 11.2% to $25.48 following upbeat results.</li>
<li>Comstock Resources, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/crk#NYSE">CRK</a>) gained 10.7% to $8.35.</li>
<li>Antero Resources Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ar#NYSE">AR</a>) rose 10.5% to $25.89.</li>
<li>LivaNova PLC (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/livn#NASDAQ">LIVN</a>) jumped 8.8% to $57.28 following upbeat earnings.</li>
<li>EQT Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/eqt#NYSE">EQT</a>) gained 8.8% to $36.69.</li>
<li>Wix.com Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wix#NASDAQ">WIX</a>) gained 8.6% to $136.15 following fourth-quarter results.</li>
<li>Bausch + Lomb Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/blco#NYSE">BLCO</a>) gained 8.6% to $15.84 after reporting quarterly results.</li>
<li>NeoGenomics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/neo#NASDAQ">NEO</a>) rose 7.4% to $15.78 after the company reported better-than-expected fourth-quarter financial results and issued FY24 adjusted EPS guidance above estimates.</li>
<li>Constellium SE (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cstm#NYSE">CSTM</a>) gained 6.7% to $19.83 following quarterly results.</li>
<li>Exelon Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/exc#NASDAQ">EXC</a>) rose 3.9% to $36.07 following strong results.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/markets/cryptocurrency/24/02/37237721/bitcoin-falls-below-51-000-starknet-becomes-top-loser"> Bitcoin Falls Below $51,000; Starknet Becomes Top Loser </a>

Craig-Hallum analyst George Sutton upgrades The Hackett Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCKT#NASDAQ">HCKT</a>) from Hold to Buy.

Upgrades

Craig-Hallum Upgrades The Hackett Group to Buy

The Hackett Group Sees Q1 2024 Adj. EPS $0.36-$0.39 Vs $0.39 Est.; Revenue $72.5M-$74.0M Vs $74.806M Est.

The Hackett Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCKT#NASDAQ">HCKT</a>) reported its Q4 earnings results on Tuesday, February 20, 2024 at 04:15 PM.
Here's what investors need to know about the announcement.
<h3>Earnings</h3>
The Hackett Group beat estimated earnings by 5.41%, reporting an EPS of $0.39 versus an estimate of $0.37.
Revenue was up $2.29 million from the same period last year.
<h3>Past Earnings Performance</h3>
Last quarter the company beat on EPS by $0.02 which was followed by a 8.27% drop in the share price the next day.
Here's a look at The Hackett Group's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2023</th>
<th>Q2 2023</th>
<th>Q1 2023</th>
<th>Q4 2022</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.39</td>
<td>0.37</td>
<td>0.36</td>
<td>0.33</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.41</td>
<td>0.39</td>
<td>0.37</td>
<td>0.36</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>74.75M</td>
<td>74.50M</td>
<td>71.08M</td>
<td>68.08M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>75.86M</td>
<td>77.10M</td>
<td>71.23M</td>
<td>70.12M</td>
</tr>
</tbody>
</table>

To track all earnings releases for The Hackett Group <a href="https://www.benzinga.com/quote/HCKT/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Recap: The Hackett Group Q4 Earnings

The Hackett Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCKT#NASDAQ">HCKT</a>) reported quarterly earnings of $0.39 per share which beat the analyst consensus estimate of $0.37 by 5.41 percent. The company reported quarterly sales of $72.40 million which beat the analyst consensus estimate of $70.44 million by 2.79 percent. This is a 3.26 percent increase over sales of $70.12 million the same period last year.

The Hackett Group Q4 2023 Adj EPS $0.39 Beats $0.37 Estimate, Sales $72.40M Beat $70.44M Estimate

Accenture plc Class A Ordinary Shares (Ireland)

Accenture

ASGN

BigBear.ai Hldgs

CI&T

Cognizant Technology Solutions Corporation - Class A Common Stock

Cognizant Tech Solns

Endava plc American Depositary Shares (each representing one Class A Ordinary Share)

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

Hackett Group

Hackett Group (HCKT) Forecast

Hackett Group (NASDAQ:HCKT) Stock, Quote.Headers.trade-ideas